Certara Recognized as a Top Biopharma Workplace for 2024 Blog Post

RADNOR, PA – 2024年6月12日 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in model-informed drug development, today announced that the Company was certified as a Great Place to…

Adaptive Trial Design for Phase 1 Dose-Finding Studies Blog Post

Greater flexibility, efficiency and quicker dissemination of research findings to patient communities that stand to benefit are all potential advantages of adaptive trial design as compared to more conventional methods…

Thank you – BaseCase Demo Apps Page

BaseCase Interactive Demo Apps Learn more about BaseCase Login to BaseCaseSchedule a demo Experience BaseCase with the Interactive Demo Apps Explore our full collection of demo apps to see how...

BaseCase Demo Apps Page

BaseCase Explore our Interactive Demo Apps Learn more about BaseCase Login to BaseCaseSchedule a live demo Transform your value communication with BaseCase BaseCase makes it easy to create interactive presentations...

The State of Generative AI in Life Sciences Blog Post

ライフサイエンスにおける生成AIが、創薬、臨床試験、研究プロセスにどのように変化をもたらすかご覧頂けます。詳しくはサターラとAxendia共著のレポートをダウンロードください。